Skin Cancer After Organ Transplant: A 100x Higher Risk
If you have received an organ transplant, your risk of squamous cell carcinoma is 65 times higher than the general population. Your risk of basal cell carcinoma is 10 times higher. This is a direct consequence of the immunosuppressive drugs that keep your body from rejecting the organ — the same drugs that suppress your immune system's ability to detect and destroy cancerous cells.
Why the risk is so high
Immunosuppressive medications (cyclosporine, tacrolimus, azathioprine, mycophenolate) reduce your immune system's ability to perform immune surveillance — the process by which your body identifies and eliminates abnormal cells before they become cancer. Additionally, some immunosuppressants (azathioprine, voriconazole) cause photosensitivity, making your skin more vulnerable to UV damage.
The risk increases with time: the longer you are on immunosuppression, the higher the risk. After 20 years on immunosuppressive therapy, up to 40-50% of transplant recipients develop at least one skin cancer.
Which skin cancers are most common
In transplant recipients, the ratio of skin cancers is reversed compared to the general population. SCC becomes more common than BCC (the opposite of what occurs in immunocompetent patients). Transplant-related SCCs are also more aggressive — they grow faster, recur more often, and metastasize at higher rates (5-8% vs 2-5% in the general population).
Melanoma risk is also increased (3-4x), and Merkel cell carcinoma — a rare, aggressive skin cancer — occurs at 5-10 times the general population rate.
Screening protocol for transplant recipients
Year 1 after transplant: dermatologist every 3-6 months for full-body skin exam. Subsequent years with no skin cancer history: annually or every 6 months depending on risk. After first skin cancer: every 3-6 months indefinitely.
Monthly self-exam at home: check all skin including scalp, soles, between toes, and nails. Take photos of any moles or lesions to track changes. Pay special attention to sun-exposed areas: face, ears, neck, forearms, hands.
Sun protection is non-negotiable
For transplant recipients, sun protection is a medical necessity, not optional. SPF 50+ broad-spectrum every day, even on cloudy days. Reapply every 2 hours outdoors. Wide-brim hat and UV-protective clothing for any outdoor activity. Avoid peak sun hours (10am-4pm) whenever possible.
Some transplant centers provide photosensitivity counseling. If yours did not, ask your transplant team about sun protection as part of your post-transplant care plan.
Talk to your transplant team
Ask your transplant team whether your immunosuppression regimen can be modified if you develop skin cancers. Switching from azathioprine to mycophenolate or from calcineurin inhibitors to mTOR inhibitors (sirolimus, everolimus) has shown reduced skin cancer rates in some studies. This is a complex decision that involves balancing cancer risk against organ rejection risk.
Also ask about: nicotinamide (vitamin B3) supplements — studies show 500mg twice daily reduces new skin cancer rates in high-risk patients by 23%. Acitretin — a retinoid sometimes prescribed for transplant recipients with multiple skin cancers.
Check a suspicious spot now with our free ABCDE mole checker.
Start free ABCDE check